What is enVVeno Medical Operating Cash Flow per Share?
enVVeno Medical's operating cash flow per share for the
three
months ended in Mar. 2024 was $-0.22.
enVVeno Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.32.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 36.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 42.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for enVVeno Medical's Operating Cash Flow per Share or its related term are showing as below:
NVNO'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -54.6 Med: 27.25 Max: 56.9
Current: 36.4
During the past 9 years, enVVeno Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -54.60% per year. And the median was 27.25% per year.
NVNO's 3-Year OCF Growth Rate is ranked better than 86.61% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 2.6
vs NVNO: 36.40
enVVeno Medical Operating Cash Flow per Share Historical Data
The historical data trend for enVVeno Medical's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
enVVeno Medical Operating Cash Flow per Share Chart
Competitive Comparison of enVVeno Medical's Operating Cash Flow per Share
For the Medical Devices subindustry, enVVeno Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enVVeno Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where enVVeno Medical's Price-to-Operating-Cash-Flow falls into.
enVVeno Medical Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
enVVeno Medical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of enVVeno Medical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
enVVeno Medical (enVVeno Medical) Business Description
enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVNO has been successfully added to your 